Surprising Victories Against Old Foes: New Hope for Prevention and Control of Healthcare- Associated MRSA Infections John A. Jernigan, MD, MS Division.

Slides:



Advertisements
Similar presentations
Aim: Advance the adoption of proven strategies to improve the reliability, safety and quality of care received by patients in Tennessee hospitals.
Advertisements

ARE CAP AND HCAP TWO SEPARATE ENTITIES? Francesco Blasi Department Pathophysiology and Transplantation, University of Milan, Italy.
Is Vancomycin Obsolete for Treating Serious Staphylococcal Infections? Part I Edward L. Goodman, MD, FACP, FIDSA, FSHEA August 26, 2009.
Context  Best Care Always! (BCA), is an initiative aimed at improving patient safety and spreading improvement methods in all South African hospitals.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
TREATMENT OF PNEUMONIA IN ADVANCED DEMENTIA Sophie Allepaerts CHU- Liège Belgium.
The War Against MRSA By Cynthia Zips, M, SM(ASCP), CIC October 25, 2013 MPH 500- Fundamentals of Public Health – Section 01- Fall A 2013 Instructor: Madeline.
Antibiotic Resistance why do we care? Thursday 1/10/2008.
Costs.
Massimo Antonelli, MD Dept. of Intensive Care & Anesthesiology Università Cattolica del Sacro Cuore Rome - Italy Antibiotics: The old and the new.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Research and analysis by Avalere Health Hospitals Demonstrate Commitment to Quality Improvement October 2012.
Health Departments and Healthcare-Associated Infection Prevention Research: A New Land of Opportunity? Matthew Wise, MPH, PhD Epidemiologist, Office of.
C-1 Staphylococcus aureus Bacteremia and Endocarditis: A Bad Bug and A New Drug G. Ralph Corey M.D. Professor of Internal Medicine and Infectious Diseases.
Healthcare-associated Infections and Antibiotic Resistance
16.3 – Antibiotic Use and Resistance. Learning objectives Students should understand the following: Antibiotic resistance in terms of the difficulty of.
Methicillin-Resistant Staphylococcus aureus Infections in California Hospital Patients, 1999 – 2006 Mary Tran, PhD, MPH Niya Fong, BS Microbiology California.
Methicillin Resistant Staphylococcus aureus (MRSA): Proposed Revision of ICD-9 Codes Rachel Gorwitz, MD, MPH Division of Healthcare Quality Promotion Centers.
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
Brad Doebbeling, MD, MSc, Paul Dexter, MD, Heather Hagg, MS, Shawn Hoke, Abel Kho, MD VA HSR&D Center of Excellence, Indiana University Center for Health.
(methicillin-resistant Staphylococcus aureus)
Staphylococcal Bacteremia and Endocarditis: Epidemiological Considerations March 6, 2006 John Edwards, Jr., M.D Professor of Medicine UCLA School of Medicine.
Controlling Antimicrobial-Resistant Infections: MRSA & VRE
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
Objectives 1. To measure the prevalence of CPSA and β-lactamase positive SA in York College students. 2.To determine if gender, working in healthcare,
Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Shira Doron, MD Assistant Professor of Medicine
Designs to determine the impact of Ab resistance How do we correctly measure the outcomes of antibiotic resistance?
Antimicrobial Stewardship
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Zintars Beldavs, MS Manager Healthcare-Associated Infections Program
The role of the English Surveillance Programme on Antimicrobial Use & Resistance in improving stewardship Susan Hopkins Consultant Infectious Diseases.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Antimicrobial Resistance in Streptococcus pneumoniae Implications for Prescription Drug Labeling John H. Powers, MD Lead Medical Officer Antimicrobial.
Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.
Dutch antibiotic resistance policy
Chapter Legislative Representatives Government Affairs Update April 2014.
Production of variation Selection for/against  Pop evolves:  cumulative change in heritable characteristics in population  Nat sel can act on pop w/o.
Antibiotics have saved millions of lives Antibiotics are losing their effect.
Welcome to the Germ Farm Elizabeth Morton October 26, 2013.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
U.S. Strategies to Improve Human Antibiotic Use Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship April 13, 2016 National Center for Emerging.
KJO Hospital Infection Control Local 2176/2097 Ross Ibabao/ICCo.
Epidemiology of Hospital Acquired Infections By Alena Bosconi, Candice Smith, Dusica Goralewski SUNY Delhi Biol , Infection and Disease Dr. Marsha.
Nosocomial Infections Emergence of Antimicrobial Resistance Mazen Kherallah, MD, FCCP King Faisal Specialist Hospital & Research Center.
Strategies in the Selection of Antibiotic Therapy in the ICU Mazen Kherallah, MD, FCCP King Faisal Specialist Hospital & Research Center.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Using AMR surveillance for developing policy AMR meeting Washington 13 April 2016.
High Value Quality Improvement Presentation 6 of 6.
MRSA Jerome, Taylor, and Tate. Statistics In the US in 2003, there were an estimated 12 million doctor or emergency room visits for skin and soft tissue.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
 Central line-associated bloodstream infections (CLABSI) are a significant national problem resulting in morbidity and mortality.  According to the CDC.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
HAP and VAP Guidelines Update
Antimicrobial Stewardship
Dr.Mowna Karthick M.D MICROBIOLOGY
Professor Alan Johnson Department of HCAI & AMR
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Antibiotic Resistance: Strategic Solutions
Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm.
Evolving problems with resistant pathogens
National Center for Emerging and Zoonotic Infectious Diseases
Presentation transcript:

Surprising Victories Against Old Foes: New Hope for Prevention and Control of Healthcare- Associated MRSA Infections John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Atlanta, Georgia

What is the Preventable Fraction of Healthcare Associated Infections?

SENIC study results others

What is the Preventable Fraction of Healthcare Associated Infections? Some may have interpreted these data to mean that most healthcare associated infections are inevitable What impact has this had on the Psychology of prevention? How has this impacted how infection control programs operate?

Eliminating catheter-related bloodstream infections in the intensive care unit Berenholtz, S et al. Critical Care Medicine. 32(10): , October 2004.

Maybe the Preventable Fraction is Much Larger than we Thought? Healthcare Epidemiologists have been afraid of using the “E” word (elimination) with regard to healthcare- associated infections, but recent successes suggest that perhaps we should have been using it more.

Are such goals appropriate for the problem of antimicrobial resistance, with MRSA as a starting point?

National Nosocomial Infections Surveillance (NNIS) System Emerging Prevalence of Methicillin- Resistance Among S. aureus in U.S. Intensive Care Units

Rationale for Efforts to Prevent and Control Resistant Gram-positive Bacteria Emerging as dominant pathogens in healthcare-associated infections –for example: Between , among infections following CABG, cholecystectomy, colectomy, and total hip replacement, % S. aureus 16.6% -30.9% % S. aureus infections attributable to MRSA increased from 9.2% to 49.3% Treatment options are limited and less effective, may result in higher morbidity and mortality –Gonzalez Clin Infect Dis 1999;29:1171 –Lucas Clin Infect Dis 1998;26:1127 –Abramson ICHE 1999; 20: –Cheng et al J Hospital Infect 1988;12: –Stosor et al. Arch Intern Med 1998; 158:

Summary of Unadjusted Results of Studies Comparing Mortality of MRSA and MSSA Bacteremia Cosgrove et al. Clinical Infectious Diseases 2003:36;53-59

Rationale for Efforts to Prevent and Control Resistant Gram-positive Bacteria Prevalence of resistance leads to unfavorable antibiotic prescribing, and leads to more resistance –prevalent MRSA more glycopeptide use more glycopeptide resistance

MRSA infections add to the total S. aureus infection rate –Stamm Am J Infect Control 1993;21:70 –Boyce J Infect Dis 1993;148:763 –Chaix JAMA 1999; 282: –Jernigan ICHE 1995;16:686 –Harbarth J Hosp Infect 2000:46;43 Therefore, preventing MRSA infections should result in decreased S. aureus infection rates

“Okay, so MRSA and antimicrobial resistance in general are important problems, but they are different from bloodstream infections. It’s okay to set bold goals for preventing bloodstream infections, but we could never hope to be so successful against MRSA infection! Could we?”

Emerging Prevalence of Methicillin- Resistance Among S. aureus in U.S. Intensive Care Units

Emerging Prevalence of Methicillin- Resistance Among S. aureus in U.S. Intensive Care Units

Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002 Tiemersma et. al. Emerg Infect Dis 2004;10:

Can the experience in other countries be reproduced here?

Overall Rates Pre-intervention = 1.48 infections/1,000 pt days Post-intervention = 0.68 infections/1,000 pt days 54% reduction, p=.04 Intervention

Overall Rates Pre-intervention = 3.82 infections/1,000 pt days Post-intervention = 1.62 infections/1,000 pt days 58% reduction, p<.01 Intervention

Huang, S. IDSA 2005

There are a growing number of studies suggesting that US healthcare facilities can successfully prevent MRSA infections

A regional collaborative approach may be a good way to approach the MRSA problem: –Sharing of MRSA-carriers between facilities –Success at the community level may be more readily accepted as generalizable –Need to agree on common system for measuring outcome, but there is room for alternative approaches to prevention. One size may not fit all. –Successes can be shared and spread across the community

Summary We (healthcare epidemiologists) may have badly underestimated the preventable fraction of healthcare-associated infections Regional/community collaboratives have been effective in achieving major reductions in healthcare-associated infections MRSA is an important patient safety issue that needs addressing.

Summary (continued) MRSA infections can be prevented, even in endemic settings Regional collaboration on MRSA prevention may have particular advantages. Successful MRSA prevention across a region would represent a major advance for infection control, and would have implications for control of other antimicrobial resistant infections